Major depressive disorder (MDD) is highly prevalent across an adult’s lifetime with a risk rate of 15–18% (Malhi & Mann, 2018). Evidence shows a increase rate of MDD from adolescence with relative stability through middle age (Goodwin et al., 2022). Adults over the age of 55 are less likely to experience MDD than younger individuals but are more likely to experience sub-threshold depressive symptoms (Biella et al., 2019). Both MDD and sub-threshold depressive symptoms not only negatively impact quality of life, but also may contribute to impairments in cognitive functioning, perhaps most notably in executive functioning (Lam et al., 2014; Rock et al., 2014; Rutherford et al., 2023; Wu et al., 2019). Importantly, greater levels of depressive symptomology in older adults are associated with an increased risk of developing dementia (Morimoto et al., 2014). Thus, it is important to identify the mechanisms of depression-associated cognitive impairment earlier in the adult lifespan for the future development of interventions that can delay or prevent cognitive decline. Neuroimaging studies are particularly important for elucidating neurobiological mechanisms that contribute to both mood and cognitive dysfunction that may serve as targets for future pharmacological and non-pharmacological interventions.
There are several reasons why age may exacerbate depression-related impairments in executive functioning. Both aging(e.g., Campbell et al., 2012; Dulas and Duarte, 2016; Rey-Mermet et al., 2018) and depression are independently associated with executive dysfunction as measured by a number of neuropsychological tests (i.e. Trail Making Test, Stroop Color-Word Interference Test, Wisconsin Card Sorting Test (WCST)), across the adult lifespan. Furthermore, both age and depression are independently associated with reduced PFC volumes in regions supporting executive functioning.(Dulas & Duarte, 2016; Grahek et al., 2018, 2019; Yang et al., 2017; Zaninotto et al., 2016) For example, adults with MDD, compared to non-depressed adults, show reduced volume in multiple brain areas, most notably, right inferior frontal gyrus, dorsolateral prefrontal cortex (dlPFC), lateral orbital frontal cortex (lOFC), and anterior cingulate cortex (ACC) across age (Grieve et al., 2013; Niida et al., 2019; Pizzagalli & Roberts, 2022; Van Tol et al., 2010; Wigmore et al., 2017; Zhang et al., 2018). Even sub-threshold depressive symptoms in middle-aged and older adults are associated with smaller OFC and ACC volumes(Dotson et al., 2009a). Given the importance of these regions in executive functioning as shown in numerous fMRI and patient studies(Pizzagalli & Roberts, 2022), such reductions could contribute to the cognitive deficits observed in both depression and aging. Finally, as shown in a recent meta-analysis, depression-related executive dysfunction in both MDD and subthreshold depression is magnified by age(Dotson et al., 2020). Collectively, these results suggest that higher levels of depression may move forward the point at which cognitive impairments characteristic of aging appear.
Few studies have assessed depression-related executive dysfunction in historically minoritized people despite evidence of racial and ethnic differences in depressive symptom prevalence. Black and Hispanic adults have a lower lifetime prevalence of diagnosed MDD but higher prevalence of sub-threshold depressive symptoms than Non-Hispanic Whites adults(Abrams & Mehta, 2019; Barnes & Bates, 2017). In both Hispanic and Black adults, symptoms may increase and be more severe in the mid-to-older adult age range when compared to non-Hispanic White adults in the same age range (Abrams & Mehta, 2019; Vyas et al., 2020), and episodes of depression tend to be more severe, persistent, and disabling (e.g., Breslau et al., 2006; Williams et al., 2007). Furthermore, depressive symptoms tend to be prolonged and associated with with more severe consequences in Black adults like higher levels of distress and higher rates of treatment drop-out(Bailey et al., 2019; Barnes & Bates, 2017). Few studies have examined depression-related cognitive impairments in these racially/ethnically minoritized groups but recent evidence shows that older (> 65) Hispanic adults with depression are more susceptible to cognitive impairment than older non-Hispanic White adults (Babulal et al., 2022). Given prior evidence that age may exacerbate depression-related cognitive impairments in samples consisting largely non-Hispanic White adults (Dotson et al., 2009a; James & Duarte, 2023), it is critical to understand whether such “double jeopardy” effects are also observed in historically racially/ethnically minoritized adults and the underlying neural mechanisms of these impairments.
This pilot study aims to examine 1) the potential mediating role of PFC volumes in the relationship between depressive symptoms and executive functioning and; 2) the moderating influence of age on these associations in historically minoritized, specifically Black and Hispanic adults, and non-Hispanic White middle-aged adults. We predicted that individuals with greater levels of depressive symptoms would show lower executive functioning and smaller laterial, orbital, and/or ACC frontal volumes, with PFC volumes mediating associations between depression and executive functioning. Finally, we explored the possibility that depression-cognition associations differ between ethnoracial minorities and non-Hispanic White adults, with potentially stronger associations in racial/ethnic minority groups given some recent evidence (Babulal et al., 2022; Hokett et al., 2022). We tested the possibility that age would exacerbate these associations more for these historically minoritized groups than non-Hispanic White adults (i.e., “double jeopardy”).